XMD-17-51 (TFA)

XMD-17-51 (TFA)

• CAS Number: 2436579-93-8
• UNSPSC Description: XMD-17-51 TFA is a pyrimido-diazepinone compound that is able to modulate protein kinases[1].
• Target Antigen: Others
• Type: Reference compound
• Related Pathways: Others
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/xmd-17-51-tfa.html
• Purity: 99.46
• Solubility: DMSO : 100 mg/mL (ultrasonic)
• Smiles: O=C1N(C)C2=CN=C(NC3=CN(C4CCNCC4)N=C3)N=C2N(C)C5=CC=CC=C15.OC(C(F)(F)F)=O
• Molecular Weight: 518.49
• References & Citations: [1]WO 2014145909 A2.|[2]Yang WQ, Zhao WJ, Zhu LL, et al. XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression. Front Pharmacol. 2021;12:603453.
• Shipping Conditions: Room Temperature
• Storage Conditions: 4°C (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported